|
[1]
|
Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer[J]. Int J Surg Pathol, 2010, 18(3 Suppl):33S-36S.
|
|
[2]
|
Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management[J]. J Med Genet, 1999, 36(12):873-880.
|
|
[3]
|
李琦,于颖彦,朱正纲.家族性胃癌研究进展[J].国外医学遗传学分册,2004,27(5):299-302.
|
|
[4]
|
Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer[J]. JAMA, 2007, 297(21):2360-2372. doi: 10.1001/jama.297.21.2360
|
|
[5]
|
Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer[J]. Nature, 1998, 392(6674):402-405. doi: 10.1038/32918
|
|
[6]
|
Palli D, Galli M, Caporaso NE, et al. Family history and risk of stomach cancer in Italy[J]. Cancer Epidemiol Biomarkers Prev, 1994, 3(1):15-18.
|
|
[7]
|
Shinmura K. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations[J]. Carcinogenesis, 1999, 20(6):1127-1131. doi: 10.1093/carcin/20.6.1127
|
|
[8]
|
Kakiuchi H, Itoh F, Kusano M, et al. Familial gastric cancer in the Japanese population is frequently located at the cardiac region[J]. Tumour Biol, 1999, 20(5):235-241. doi: 10.1159/000030069
|
|
[9]
|
van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers[J]. J Med Genet, 2015, 52(6):361-374. doi: 10.1136/jmedgenet-2015-103094
|
|
[10]
|
Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines[J]. Lancet Oncol, 2020, 21(8):e386-e397. doi: 10.1016/S1470-2045(20)30219-9
|
|
[11]
|
Oliveira C, Senz J, Kaurah P, et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families[J]. Hum Mol Genet, 2009, 18(9):1545-1555. doi: 10.1093/hmg/ddp046
|
|
[12]
|
Yamada H, Shinmura K, Ito H, et al. Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population[J]. Cancer Sci, 2011, 102(10):1782-1788. doi: 10.1111/j.1349-7006.2011.02038.x
|
|
[13]
|
Zhou J, Zhao ZY, Zhang YZ, et al. Pathogenic germline mutations in Chinese patients with gastric cancer identified by next-generation sequencing[J]. Oncology, 2020, 98(8):583-588. doi: 10.1159/000505664
|
|
[14]
|
Hansford S, Kaurah P, Li-Chang H, et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond[J]. JAMA Oncol, 2015, 1(1):23-32. doi: 10.1001/jamaoncol.2014.168
|
|
[15]
|
Lerner BA, Llor X. Genetic gastric cancer risk syndromes[J]. Curr Treat Options Gastroenterol, 2020, 18(4):604-615. doi: 10.1007/s11938-020-00312-z
|
|
[16]
|
Gamble LA, Heller T, Davis JL. Hereditary diffuse gastric cancer syndrome and the role of CDH1[J]. JAMA Surg, 2021, 156(4):387. doi: 10.1001/jamasurg.2020.6155
|
|
[17]
|
Seevaratnam R, Coburn N, Cardoso R, et al. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer[J]. Gastric Cancer, 2012, 15(Suppl 1):S153-S163.
|
|
[18]
|
El Rami FE, Barsoumian HB, Khneizer GW. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell[J]. Ther Adv Med Oncol, 2020, 12:1758835920967238.
|
|
[19]
|
Hamilton JG, Long JM, Brandt AC, et al. Patients' medical and psychosocial experiences after detection of a CDH1 variant with multigene panel testing[J]. JCO Precis Oncol, 2019, 3:18.
|
|
[20]
|
Stewart DR, Frone MN, Chanock SJ. Stomaching multigene panel testing: what to do about CDH1[J]? JNCI J Natl Cancer Inst, 2020, 112(4):325-326.
|
|
[21]
|
van der Post RS, van Dieren J, Grelack A, et al. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria[J]. Gastrointest Endosc, 2018, 87(2):397-404. doi: 10.1016/j.gie.2017.04.016
|
|
[22]
|
Mi EZ, Mi EZ, di Pietro M, et al. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status[J]. Gastrointest Endosc, 2018, 87(2):408-418. doi: 10.1016/j.gie.2017.06.028
|
|
[23]
|
Lewis FR, Mellinger JD, Hayashi A, et al. Prophylactic total gastrectomy for familial gastric cancer[J]. Surgery, 2001, 130(4):612-617.
|
|
[24]
|
Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research[J]. J Med Genet, 2010, 47(7):436-444. doi: 10.1136/jmg.2009.074237
|
|
[25]
|
Gertler R, Rosenberg R, Feith M, et al. Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review[J]. Am J Gastroenterol, 2009, 104(11):2838-2851. doi: 10.1038/ajg.2009.456
|
|
[26]
|
Sugimoto S, Yamada H, Takahashi M, et al. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene[J]. Gastric Cancer, 2014, 17(4):745-749. doi: 10.1007/s10120-013-0278-2
|
|
[27]
|
张宁媛,黄国宁,范立青,等.胚胎植入前遗传学诊断与筛查实验室技术指南[J].生殖医学杂志,2018,27(9):819-827. doi: 10.3969/j.issn.1004-3845.2018.09.001
|
|
[28]
|
Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes[J]. Am J Gastroenterol, 2015, 110(2):223-262. doi: 10.1038/ajg.2014.435
|
|
[29]
|
Gupta S, Provenzale D, Llor X, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019[J]. J Natl Compr Cancer Netw, 2019, 17(9):1032-1041. doi: 10.6004/jnccn.2019.0044
|
|
[30]
|
Herzig DO, Buie WD, Weiser MR, et al. Clinical practice guidelines for the surgical treatment of patients with lynch syndrome[J]. Dis Colon Rectum, 2017, 60(2):137-143. doi: 10.1097/DCR.0000000000000785
|
|
[31]
|
Balmaña J, Balaguer F, Cervantes A, et al. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines[J]. Ann Oncol, 2013, 24 Suppl 6:vi73-80.
|
点击查看大图
下载:
